News

Aptahem starts close collaboration with leading research groups at the Nencki Institute in Warsaw

Aptahem today announced that an extensive collaboration has begun with the Nencki Institute of Experimental Biology. Aptahem and various expert groups within the Institute will jointly examine the effects of the company’s developmental drug candidate, APTA-1. The Nencki Institute...

Read More

Aptahem enter cooperation agreement with leading research institute in hematology

Aptahem announce they have entered a cooperation agreement with the Institute of Hematology and Blood Transfusion in Warsaw (IHIT), to identify APTA-1’s inhibitory mechanisms in the coagulation system. IHIT is Poland’s most prestigious hematology research institute and reference hospital....

Read More